Journal profile

Therapeutic advances in cardiovascular disease

Publisher: Sage Publications
ISSN1753-9447 | 1753-9455 FormatPrint StatusCurrently indexed

Journal Citation Impact

Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.

Impact Factor
3.50
Citation rate 4.71 207 total citations
h5-index 16 h5 depth signal
Cited share 86.7% 39 of 45
Total citations 207 Citation footprint
Metric signal 4.40 External metric anchor
Self-citation 0.5% 1 self-citations

Citations Trend

Monthly Publications Cadence

Citing Geographic Demographics

United States 82
United Kingdom 22
Germany 19
India 16
Italy 11

Citing Fields of Research

Cardiology 168
Vascular Disorders 29
Diabetes 19
Lipids 11
Autonomic Function 10

Publishing Activity & Reach

Volume, recency, access pattern, and citing-community signals from the journal analytics record.

All-time article footprint 532 Articles tracked across the journal lifetime
Indexed publication set 45 39 cited publications
Last 12 months 24 2.4 publications/month
Open access share 100.0% 24 OA publications in the last year
Leading citing country United States 82 citing publications
Leading citing field Cardiology 168 citing publications
Latest tracked publication 28 September 2026 10 recent records available

Coverage & Indexing History

MEDLINE
v1n1, Oct. 2007-
PubMed
v1n1, Oct. 2007-
PMC
Active Coverage

Research Focus & Classification

Indexed Subjects

Cardiology

Broad Categories

Cardiology Therapeutics Vascular Diseases

MeSH Descriptors

Cardiovascular Diseases

Latest Publications

Recent article records with DOI-first linking and condensed abstracts.

01
Akimasa Morisaki, Kokoro Yamane, Toshihiko Shibata
Coronary artery aneurysm is a rare condition commonly treated with conventional surgery under cardiopulmonary bypass because of its complexity. Here, we present a patient who underwent minimally invasive off-pump coronary surgery via lef...
03
Ibrahim Mortada, Aaron W. Lee, Dalton Buckingham et al.
Background: Sex-related differences are well recognized in heart failure with preserved ejection fraction (HFpEF), but real-world data describing clinical outcomes by sex among patients with obesity and HFpEF treated with tirzepatide rem...
04
Qichen Xu, Zheng Xu, Liangwan Chen et al.
Background: Despite the increasing adoption of minimally invasive approaches for valvular heart disease, the learning trajectory for complex thoracoscopic double valve replacement (DVR) remains largely uncharacterized. Objectives: To eva...
05
Yujing Zhang, Jing Wang, Chengliang Qu et al.
Background: Endovascular aneurysm repair (EVAR) is used to treat patients with abdominal aortic aneurysm (AAA) who have suitable anatomy, while complex AAAs often require fenestrated and branched stent grafts, necessitating further refin...
07
Enes Alıç, Mohamed Niang, Haşim Tüner et al.
Background: Drug-coated balloons (DCBs) represent a “leave-nothing-behind” strategy in percutaneous coronary intervention (PCI), particularly for small vessel disease and in-stent restenosis. However, long-term comparative real-world dat...
08
Wenhao Liu, Qian Chen, Tucheng Huang et al.
Background: Current guidelines lack instruction on fluid administration for patients with critically ill heart failure (HF) in the intensive care unit. Objectives: This study aims to compare the risk of mortality and acute kidney injury ...

Bibliographical & Catalog Notes

Title from cover.

Latest issue consulted: Vol. 2, no. 1 (Feb. 2007).

Also issued online.